BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

XellSmart Achieves World-First Patient Dosing in Pioneering iPSC-Derived Cell Therapy Trial for Spinal Cord Injury

XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved regis...

July 30, 2025 | News

Tigermed Acquires Japan’s First Imaging CRO Micron to Bolster Asia-Pacific Medical Imaging Capabilities

Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, annou...

July 30, 2025 | News

Alphamab Oncology’s HER2-Targeting ADC JSKN003 Secures FDA Orphan Drug Designation for Gastric and GEJ Cancers

Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Foo...

July 29, 2025 | News

Biocytogen Expands Preclinical Capabilities Across Asia and the U.S. with Over 1,000 Humanized Mouse Models

Biocytogen (HKEX: 02315), an international biotechnology company that drives new drug development with innovative technologies, announced that its pr...

July 29, 2025 | News

Suzhou’s Kintor Pharma Reports Positive Phase II Results for KX-826 in AGA Trial, Clears Path for Phase III

Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and po...

July 28, 2025 | News

China’s DualityBio Secures FDA Fast Track for Next-Gen HER3 ADC DB-1310 in Advanced Lung Cancer

DualityBio announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting a...

July 23, 2025 | News

WuXi Biologics China PFS Site Clears FDA Inspection

WuXi Biologics’ pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-qu...

July 22, 2025 | News

Fangzhou and Novo Nordisk Forge Strategic Alliance to Revolutionise Chronic Disease Management with AI

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, ...

July 21, 2025 | News

Concord Healthcare Delivers China’s First Proton Therapy for Choroidal Malignant Melanoma

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), whic...

July 15, 2025 | News

SCG Cell Therapy Secures China NMPA IND Approval for First Cell Therapy Targeting Chronic Hepatitis B

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announ...

July 08, 2025 | News

InnoCare Pharma Receives IND Approval in China for Novel B7-H3 Targeted ADC ICP-B794

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the Inves...

July 07, 2025 | News

Akeso Doses First Patient in Phase Ia Trial of AK146D1, the World’s First Bispecific ADC Targeting Trop2 and Nectin4

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...

July 04, 2025 | News

Joincare Group Secures Greater China Rights to BRII-693 in Pact With Brii Biosciences

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to a...

July 04, 2025 | News

Thermo Fisher and CYDF Celebrate 10 Years of Inspiring Young Minds Across China Through Little Scientists Program

Thermo Fisher Scientific, the world leader in serving science, together with the China Youth Development Foundation (CYDF), proudly marked the 10th anniver...

July 03, 2025 | News

Stay Connected